2005 - Fellow of the American Association for the Advancement of Science (AAAS)
Christoph Plass mainly investigates DNA methylation, Epigenetics, Genetics, Cancer research and Molecular biology. His DNA methylation research integrates issues from Histone and Methylation. Christoph Plass has researched Methylation in several fields, including Tumor suppressor gene, Colorectal cancer, Transcription factor and Restriction landmark genomic scanning.
His Epigenetics study incorporates themes from Cancer, Internal medicine, Epigenesis and Epigenome. His studies in Cancer research integrate themes in fields like Gene silencing, Chromatin remodeling, Estrogen receptor and Chronic lymphocytic leukemia. His work carried out in the field of Molecular biology brings together such families of science as Prostate, Fusion gene, SWI/SNF, Gene duplication and Regulation of gene expression.
His primary areas of study are DNA methylation, Epigenetics, Cancer research, Methylation and Genetics. His DNA methylation study integrates concerns from other disciplines, such as Molecular biology and Chronic lymphocytic leukemia. His study explores the link between Epigenetics and topics such as Histone that cross with problems in Chromatin.
His Cancer research research includes elements of Carcinogenesis, Tumor suppressor gene, Gene silencing and microRNA. As a part of the same scientific study, he usually deals with the Methylation, concentrating on Epigenetics of physical exercise and frequently concerns with RNA-Directed DNA Methylation. Christoph Plass has included themes like Computational biology and Cancer epigenetics in his Epigenomics study.
The scientist’s investigation covers issues in DNA methylation, Epigenetics, Cancer research, Computational biology and Methylation. His work in DNA methylation tackles topics such as DNA which are related to areas like CpG site. His Epigenetics study combines topics from a wide range of disciplines, such as Cancer, Enhancer, Cell biology, Histone and Epigenome.
The concepts of his Cancer research study are interwoven with issues in Gene expression, Transcription factor, microRNA, Juvenile myelomonocytic leukemia and Chronic lymphocytic leukemia. His Methylation research is multidisciplinary, relying on both Enhancer binding, Oncology, Gene mutation, Promoter and DNA repair. His Gene research is classified as research in Genetics.
Christoph Plass mostly deals with DNA methylation, Epigenetics, Cancer research, Histone and Genetics. His DNA methylation research includes themes of Transcriptome, Methylation and Internal medicine. His Epigenetics research is multidisciplinary, incorporating elements of Carcinogenesis, Reprogramming, Immunology, Cell biology and Epigenome.
He interconnects Cancer cell, Mutant, Chronic lymphocytic leukemia and H3F3B in the investigation of issues within Cancer research. His Histone research incorporates themes from Osteosarcoma, Giant-cell tumor of bone, Chromatin, Long terminal repeat and PTEN. His research on Genetics often connects related topics like Andrology.
This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.
Epigenetic differences arise during the lifetime of monozygotic twins
Mario F. Fraga;Esteban Ballestar;Maria F. Paz;Santiago Ropero.
Proceedings of the National Academy of Sciences of the United States of America (2005)
Driver mutations in histone H3.3 and chromatin remodelling genes in paediatric glioblastoma
Jeremy Schwartzentruber;Andrey Korshunov;Xiao Yang Liu;David T.W. Jones.
Aberrant CpG-island methylation has non-random and tumour-type-specific patterns.
Joseph F. Costello;Joseph F. Costello;Michael C. Frühwald;Michael C. Frühwald;Dominic J. Smiraglia;Laura J. Rush.
Nature Genetics (2000)
Hotspot mutations in H3F3A and IDH1 define distinct epigenetic and biological subgroups of glioblastoma.
Dominik Sturm;Hendrik Witt;Hendrik Witt;Volker Hovestadt;Dong Anh Khuong-Quang.
Cancer Cell (2012)
Pan-cancer analysis of whole genomes
Peter J. Campbell;Gad Getz;Jan O. Korbel;Joshua M. Stuart.
Reduced H3K27me3 and DNA Hypomethylation Are Major Drivers of Gene Expression in K27M Mutant Pediatric High-Grade Gliomas
Sebastian Bender;Sebastian Bender;Yujie Tang;Anders M. Lindroth;Volker Hovestadt.
Cancer Cell (2013)
Principles for the post-GWAS functional characterization of cancer risk loci
Matthew L Freedman;Alvaro N A Monteiro;Simon A Gayther;Simon A Gayther;Gerhard A Coetzee.
Nature Genetics (2011)
Maftools: efficient and comprehensive analysis of somatic variants in cancer.
Anand Mayakonda;Anand Mayakonda;De Chen Lin;Yassen Assenov;Yassen Assenov;Christoph Plass;Christoph Plass.
Genome Research (2018)
Downregulation of death-associated protein kinase 1 (DAPK1) in chronic lymphocytic leukemia.
Aparna Raval;Stephan M. Tanner;John C. Byrd;Elizabeth B. Angerman.
MGMT testing—the challenges for biomarker-based glioma treatment
Wolfgang Wick;Michael Weller;Martin van den Bent;Marc Sanson.
Nature Reviews Neurology (2014)
International Journal of Cancer
(Impact Factor: 7.316)
If you think any of the details on this page are incorrect, let us know.
We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below: